𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Timeliness of review and approval of new drugs in Canada from 1999 through 2001: Is progress being made?

✍ Scribed by Nigel S.B. Rawson

Book ID
117321388
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
926 KB
Volume
25
Category
Article
ISSN
0149-2918

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

news : Companies home in on Canada : Sig
news : Companies home in on Canada : Sign of the times : More data offshore Vietnam : Enterprise and LASMO a possible item : Thailand takeover by Chevron : Long life expectancy predicted for Exxon : People in the News : Yemen Progress : Transition block deal in Brazil : Bid to put Sao Tome and Principe on oil map : Angola 3D programme builds up : Kazakhstan gas field win : Data management choice is made : Survey design tool for reservoir imaging : US policy is hindering Caspian development, Senators told : Nigerian cheer for Statoil : Veritas results reveal oil price pressures : Hiccup for Geoscience merger deal? : GeoFrame offers seamless flow from interpretation to reservoir modelling
📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB
Preambles and resolutions relating to re
Preambles and resolutions relating to revision of U. S. copyright and patent laws**This draft was prepared by Dr. F. E. Stewart, chairman of the Committee on Patents and Trade-marks, A. Ph A., for Dr. S. Solis Cohen, Chairman of the Committee on Scope, U. S. P. IX. It was also submitted in the report of the Committee on Patents and Trade Marks, of the Merchants’ and Manufacturers’ Association of Philadelphia, composed of Ernest T. Trigg (President Philadelphia Chamber of Commerce), Charles A. Wagner and Dr. F. E. Stewart, and approved. The matter in italics is suggested for revising the present U. S. Copyright and Patent Laws, and the subject is submitted for study by the members of the American Pharmaceutical Association, preparatory to its discussion at the next annual convention. The Committee received instructions at the last meeting to proceed with the revision, and the Chairman is desirous that the subject be carefully considered from every viewpoint.The Committee believes that all ambiguity now existing in the law should be removed in the revision. Provision should also be made in the law so that the inventor of a new process can secure a royalty from the original patentee. Attention is again directed that matter in italics embody the suggestions of the Committee for additions to the copyright, patent and trademark laws.—Editor.
📂 Article 📅 1917 🏛 Elsevier ⚖ 998 KB 👁 1 views
ANNOUNCEMENTS: 4th Annual Meeting of the
ANNOUNCEMENTS: 4th Annual Meeting of the Association for Ocular Pharmacology and Therapeutics (AOPT) The Marriott, Irvine, CA, USA 28–31 January 1999, Keystone Symposia Ocular Cell & Molecular Biology (OCMB) Announces Dean Bok, Ph.D. as the winner of the first OCMB Prize, Keystone OCMB Symposium, 1999 Keystone Colorado 5–10 February 1999, Call for Abstracts and Registration Organizers: Steven E. Wilson and Joe Hollyfield Registration and Abstract Forms available from: Keystone Symposia on Molecular and Cellular Biology Drawer 1630 Silverthorn, Colorado 80498 Telephone: 800-253-0685 Fax: 970-262-1525 E-mail: [email protected], XIV International Congress of Eye Research Santa Fe, New Mexico 15–20 October 2000, XV International Congress of Eye Research (2002) Proposals for the International Congress of Eye Research meeting to be held in the year 2002 are now being accepted by the ISER Council. The Jules François Prize of the Belgian Ophthalmological Societies 2000 The aim of the Jules François Prize is to encourage scientific research in ophthalmology. The prize of 10.000 U.S. Dollars will be awarded to a young scientist who has made an important contribution to ophthalmology. Eligibility: All topics in the field of fundamental and/or clinical research in ophthalmology will be considered. The application should be sent jointly with a curriculum vitae, the list of all publications and 3 copies of the candidates' 10 most relevant publications. The candidate should not be older than 40 years by 31 December 1999. Mailing Address: Jules François Foundation Secretary Prof. Dr. M. Hanssens Dienst Oogheelkunde De Pintelaan 185 B-9000 Gent, Belgium
📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 235 KB